Stock MYX MAYNE PHARMA GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Market Closed - Australian S.E.
Other stock markets
 02:10:11 2024-05-03 am EDT 		5-day change 1st Jan Change
7.37 AUD +5.14% Intraday chart for Mayne Pharma Group Limited +6.35% +19.84%
Feb. 26 Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% MT
Feb. 25 Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mayne Pharma Group Limited Approves Election of Anne Lockwood
CI
Mayne Pharma Gets Go-Ahead for Resignation of EY as Auditor
MT
Mayne Pharma Group Limited Announces Retirement of Carolyn Myers from the Board At the End of July 2023
CI
Services Data and Factory Orders Anticipation Drag Exchange-Traded Funds, Stock Futures Lower
MT
Mayne Pharma Group Limited Announces Executive Changes Effective from 1 October 2022
CI
Mayne Pharma Group Limited Appoints Mr. Shawn Patrick O'brien as Chief Executive Officer
CI
Mayne Pharma Group Limited Announces Management Changes
CI
Mayne Pharma Group CEO to Retire
MT
Scott Richards Plans to Retire as CEO of Mayne Pharma Group Limited
CI
Mayne Pharma Names New CFO; Shares Jump 5%
MT
Ann Custin Accepts to Join the Board and Audit and Risk Committee of Mayne Pharma Group Limited
CI
Mayne Pharma Group Limited Announces Management Changes
CI
Mayne Pharma Group Limited Appoints Carolyn Myers to the Board
CI
Mayne Pharma Group Limited Announces Board Changes
CI
Mayne Pharma Group Limited Appoints Peter Paltoglou as Chief Financial Officer
CI
Mayne Pharma : Toni Nesci named head of Mayne Contract Services and New Website Launched
AQ
Mayne Pharma Group Limited Announces Executive Changes
CI
Mayne Pharma Group Limited Announces the Cessation of Ron Best as Director Effective from 22 November 2019
CI
Mayne Pharma Group Limited Announces Retirement of Ron Best as Non-Executive Director
CI
Mayne Pharma Group Limited Announces FDA Approves Trade Name Lexette(TM) (halobetasol propionate) Foam, 0.05%
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MYX Stock
  4. News Mayne Pharma Group Limited
  5. Insiders